Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients with Newly Diagnosed Glioblastoma

被引：0
|
作者：
Shenouda, G. [1 ]
Petrecca, K. [2 ]
Abdulkarim, B. S. [3 ]
Owen, S. [1 ]
Panet-Raymond, V. [3 ]
Diaz, R. [4 ]
Guiot, M. C. [5 ]
Carvalho, T. [6 ]
Charbonneau, M. [1 ]
Hall, J. [7 ]
Souhami, L.
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Neurosurg, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Dept Radiat Oncol, Montreal, PQ, Canada
[4] Montreal Neurol Hosp, Montreal, PQ, Canada
[5] Montreal Neurol Inst Hosp, Dept Pathol, Montreal, PQ, Canada
[6] McGill Univ, Montreal, PQ, Canada
[7] Montreal Neurol Hosp, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
211
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [1] PHASE 2 TRIAL OF NEOADJUVANT METFORMIN AND TEMOZOLOMIDE FOLLOWED BY HYPOFRACTIONATED ACCELERATED RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT METFORMIN AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOM
    Shenouda, George
    Petrecca, Kevin
    Abdulkarim, Bassam
    Owen, Scott
    Panet-Raymond, Valerie
    Diaz, Roberto
    Guiot, Marie-Christine
    Hall, Jeffery
    Charbonneau, Melissa
    Carvalho, Tatiana
    Souhami, Luis
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S26 - S26
  • [2] A Phase 2 Study of Neo-adjuvant Metformin and Temozolomide followed by Hypofractionated Accelerated RadioTherapy (HART) with Concomitant and Adjuvant Metformin and Temozolomide (TMZ) in Patients with Glioblastoma
    Shenouda, G.
    Souhami, L.
    Petrecca, K.
    Panet-Raymond, V.
    Owen, S.
    Diaz, R. J.
    Hall, J.
    Guiot, M. C.
    Carvalho, T.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S21 - S21
  • [3] A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma
    Shenouda, George
    Souhami, Luis
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Guiot, Marie-Christine
    Corredor, Andrea Gomez
    Abdulkarim, Bassam
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 487 - 494
  • [4] Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma
    Yusuf, Mehran
    Ugiliweneza, Beatrice
    Amsbaugh, Mark
    Boakye, Maxwell
    Williams, Brian
    Nelson, Megan
    Hattab, Eyas M.
    Woo, Shiao
    Burton, Eric
    ONCOLOGY, 2018, 95 (01) : 39 - 42
  • [5] Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience
    Jalali, R.
    Basu, A.
    Gupta, T.
    Munshi, A.
    Menon, H.
    Sarin, R.
    Goel, A.
    BRITISH JOURNAL OF NEUROSURGERY, 2007, 21 (06) : 583 - 587
  • [6] Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients
    Behm, Timo
    Horowski, Antonia
    Schneider, Simon
    Bock, Hans Christoph
    Mielke, Dorothee
    Rohde, Veit
    Stockhammer, Florian
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (10) : 2142 - 2146
  • [7] Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
    Omuro, Antonio
    Beal, Kathryn
    Gutin, Philip
    Karimi, Sasan
    Correa, Denise D.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Chan, Timothy A.
    Gavrilovic, Igor T.
    Nolan, Craig
    Hormigo, Adilia
    Lassman, Andrew B.
    Mellinghoff, Ingo
    Grommes, Christian
    Reiner, Anne S.
    Panageas, Katherine S.
    Baser, Raymond E.
    Tabar, Viviane
    Pentsova, Elena
    Sanchez, Juan
    Barradas-Panchal, Renata
    Zhang, Jianan
    Faivre, Geraldine
    Brennan, Cameron W.
    Abrey, Lauren E.
    Huse, Jason T.
    CLINICAL CANCER RESEARCH, 2014, 20 (19) : 5023 - 5031
  • [8] Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma
    Minniti, Giuseppe
    De Sanctis, V.
    Muni, R.
    Rasio, D.
    Lanzetta, G.
    Bozzao, A.
    Osti, M. F.
    Salvati, M.
    Valeriani, M.
    Cantore, G. P.
    Enrici, R. Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (01) : 95 - 100
  • [9] Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma
    Giuseppe Minniti
    V. De Sanctis
    R. Muni
    D. Rasio
    G. Lanzetta
    A. Bozzao
    M. F. Osti
    M. Salvati
    M. Valeriani
    G. P. Cantore
    R. Maurizi Enrici
    Journal of Neuro-Oncology, 2009, 91 : 95 - 100
  • [10] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
12345